Pathfinder Bancorp, the Oswego, New York-based holding company for Pathfinder Bank, remains in the early stages of recovering from its 2025 review. The company completed a thorough commercial loan review late that year and built risk-based reserves, which led to a net loss in the fourth quarter. The first two quarters of 2026 brought sequential improvement in net income and EPS. Given the bank's modest size and limited analyst coverage, each earnings release takes on greater importance as investors evaluate credit trends, margin stability, and the sustainability of the rebound amid changing interest rates.
Wall Street coverage of Pathfinder Bancorp is sparse, so investors lean heavily on management commentary and internal trends. In the second quarter of 2026, the bank posted EPS of $0.42, up from $0.38 in the first quarter. Management credited steady credit results, careful loan and deposit pricing, and additional net interest income from moving excess liquidity into available-for-sale securities. I also checked this using Tickeron's AI Screener to see how the stock compares to others in the industry.
Important items in the upcoming report include net interest income, net interest margin, nonperforming loans, and the efficiency ratio. The first-quarter 2026 NIM stood at 3.10%, down from 3.31% a year earlier, as lower loan yields were only partly offset by reduced funding costs.
Investor sentiment ahead of the third-quarter report is cautiously optimistic but remains tied to credit performance. Shares have stayed in a relatively narrow range, recently quoted near $16.72 in late October 2026. The 2025 steps to reclassify legacy commercial loans and increase reserves reduced some uncertainty, yet elevated nonperforming loans continue to draw attention. Those loans totaled about $38.2 million, or roughly 4.26% of total loans, at the end of the first quarter of 2026. Any further rise could weigh on the stock.
Beyond the immediate release, the main question is whether Pathfinder Bancorp can maintain its margin and earnings recovery while preserving credit standards. Management has indicated plans to strengthen its core deposit franchise and pursue quality commercial loan growth, along with expanding residential and consumer lending in Central New York.
Several areas stand out for monitoring. Net interest margin direction will be telling, as the bank seeks to counter lower loan yields through lower deposit costs and redeploying liquidity into securities. Credit trends, especially the resolution of nonperforming loans and net charge-offs, could shift results materially. Deposit costs and the ability to attract low-cost funding will also affect profitability as rates change. The efficiency ratio and noninterest expense growth merit attention after earlier salary increases lifted costs. The $0.10 quarterly dividend continues to provide support for income investors. No updated guidance accompanied the preview, so management's remarks will be parsed for any fresh signals on credit and margins.
I frequently turn to Tickeron's AI-driven platforms when preparing for earnings like this one. The AI Screener helps me quickly compare regional banks on fundamentals and technical signals, while the AI Trend Prediction Engine offers additional context on sector movements. These resources have become a regular part of my workflow for identifying patterns that might not stand out in traditional analysis.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
PBHC broke above its upper Bollinger Band on October 28, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options. The A.I.dvisor looked at 51 similar instances where the stock broke above the upper band. In 36 of the 51 cases the stock fell afterwards. This puts the odds of success at 71%.
The Moving Average Convergence Divergence Histogram (MACD) for PBHC turned negative on September 30, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 49 similar instances when the indicator turned negative. In 28 of the 49 cases the stock turned lower in the days that followed. This puts the odds of success at 57%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where PBHC declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 60%.
The Aroon Indicator for PBHC entered a downward trend on October 23, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 35 of 59 cases where PBHC's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 59%.
The Momentum Indicator moved above the 0 level on October 28, 2026. You may want to consider a long position or call options on PBHC as a result. In 55 of 127 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 43%.
Following a +1.32% 3-day Advance, the price is estimated to grow further. Considering data from situations where PBHC advanced for three days, in 93 of 191 cases, the price rose further within the following month. The odds of a continued upward trend are 49%.
The Tickeron PE Growth Rating for this company is 1 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 45 (best 1 - 100 worst), indicating steady price growth. PBHC’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 77 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. PBHC’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 56, placing this stock worse than average.
The Tickeron SMR rating for this company is 82 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of 96 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.856) is normal, around the industry mean (1.268). PBHC's P/E Ratio (1714.000) is considerably higher than the industry average of (13.299). Projected Growth (PEG Ratio) (0.560) is also within normal values, averaging (1.190). Dividend Yield (0.023) settles around the average of (0.035) among similar stocks. PBHC's P/S Ratio (1.729) is slightly lower than the industry average of (3.738).
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a savings bank
Industry RegionalBanks